Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated gene therapy for cystic fibrosis (pGM169/GL67A)
2011-004761-33Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Dec 2011
- Modality
- Gene Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cystic fibrosis (CF) comparing pGM169/GL67A gene therapy with Placebo (2 arms). Primary endpoint: Relative change in percent predicted FEV1 from baseline after the 12th dose. Started Dec 2011; status: completed.
02
Drugs
pGM169 + GL67A
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2011-004761-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004761-33.